THERIVA BIOLOGICS

VCN-01

Gene / Cell Therapy

In combination with CAR-T cells for mesothelin positive tumors (ovarian/ pancreatic)
1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical